Congenital combined deficiency of factor VII and X in a patient due to accidental diphacinone intoxication

• References

• 1 Mariani G, Herrmann FH, Dolce A. et al. Clinical phenotypes and factor VII genotype in congenital factor VII deficiency. Thromb Haemost 2005; 93: 481-487.
• 2 Uprichard J, Perry DJ. Factor X deficiency. Blood Rev 2002; 16: 97-110.
• 3 Girolami A, Ruzzon E, Tezza F. et al. Congenital combined defects of factor VII: a critical review. Acta Haematol 2007; 117: 51-56.
• 4 Girolami A, Ruzzon E, Tezza F. et al. Congenital FX deficiency combined with other clotting defects or with other abnormalities: a critical evaluation of the literature. Haemophilia 2008; 14: 323-328.
• 5 Boxus G, Slacmeulder M, Ninane J. Combined hereditary deficiency in factors VII and X revealed by a prolonged partial thromboplastin time. Arch Pedi- atr 1997; 4: 44-47.
• 6 Menegatti M, Karimi M, Garagiola I. et al. A rare inherited coagulation disorder: combined homozygous factor VII and factor X deficiency. Am J Hema-tol 2004; 77: 90-91.
• 7 Pfeiffer RA, Ott R, Gilgenkrantz S. et al. Deficiencyof coagulation factors VII and X associated withdeletion of a chromosome 13 (q34). Evidence fromtwo cases with 46,XY,t(13; Y)(q11; q34). HumGenet 1982; 62: 358-360.
• 8 Ott R, Pfeiffer RA. Evidence that activities of coagu-lation factors VII and X are linked to chromosome13 (q34). Hum Hered 1984; 34: 123-126.
• 9 Peyvandi F, Jenkins PV, Mannucci PM. et al. Molec-ular characterisation and three-dimensional struc-tural analysis of mutations in 21 unrelated familieswith inherited factor VII deficiency. Thromb Hae-most 2000; 84: 250-257.
• 10 Peyvandi F, Garagiola I, Palla R. et al. Role of the 2adenine (g.11293_11294insAA) insertion poly-morphism in the 3’ untranslated region of the fac-tor VII (FVII) gene: molecular characterization of apatient with severe FVII deficiency. Hum Mutat 2005; 26: 455-461.
• 11 Herrmann FH, Wulff K, Auerswald G. et al. FactorVII deficiency: Clinical manifestation of 717 subjects from Europe and Latin America with mu-tations in the factor 7 gene. Haemophilia 2009; 15: 267-280.
• 12 Pinotti M, Camire RM, Baroni M. et al. Impaired prothrombinase activity of factor X Gly381Asp results in severe familial CRM+ FX deficiency. Thromb Haemost 2003; Feb 89: 243-248.
• 13 Ren P, Stark PY, Johnson RL. et al. Mechanism of action of anticoagulants: correlation between the inhibition of prothrombin synthesis and the regeneration of vitamin Kj from vitamin Kj epoxide. J Pharmacol Exp Ther 1977; 201: 541-546.
• 14 Watt BE, Proudfoot AT, Bradberry SM. et al. Anticoagulant rodenticides. Toxicol Rev 2005; 24: 259-269.
• 15 Murphy MJ. Rodenticides. Vet Clin North Am Small Anim Pract 2002; 32: 469-484.